The importance of innovative design in enhancing the safety of the next generation anti-CD47 therapeutics

CO005 - CellOrigin Biotech

CO001 - CellOrigin Biotech

https://dx.doi.org/10.1136/jitc-2024-SITC2024.1122

Sittana Matar1,2; Seham Skah1; Liza E Diomande1; Kjetil Hestdal1; Rolf Pettersen1; Nina Richartz1

Oct 4, 2024